Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Randomized, Single Ascending Dose, Double-blinded, Placebo Controlled, Multi-center Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

NCT01746420 is registered in ClinicalTrials.gov with BioMimetic Therapeutics as lead sponsor.

NCT NCT01746420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01746420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Randomized, Single Ascending Dose, Double-blinded, Placebo Controlled, Multi-center Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis
Lead sponsor
BioMimetic Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
December 12, 2012
Completion date
October 21, 2014
Enrollment
100 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lateral epicondylitis